Resistant Blood Hypertension and its Relationship to Sodium and Potassium Ingestion

Backgroud: The relationship between resistant hypertension (HAR) and sodium remains controversial. This study aimed to evaluate the relationship between resistant hypertension and urinary sodium and potassium excretion. Methods: It is a cross-sectional study. Socio-demographic, clinical and laboratory variables were evaluated. The estimated consumption of Na + and K + in 24 hours was determined by the formula of Kawasaki amp Tanaka (2002) and defined as high for Na +gt 4g, and potassiumgt 4.2g. Results: Fifty-one patients with HAR were evaluated. Sodium intake increased by 56% and was associated with HAR in patients with: age between 40 and 65 years (OR = 14.91, 95% CI 1.37-162.07) Potassium intakegt 4.2g (OR = 8.27 95% CI: 1.12- HYPERLINK quotcall to: 1.12% 20-% 2061.16quot 61.16) and Caucasians (OR = 23.17 95% CI 1.23-147.85). High potassium intake was negatively associated with uncontrolled HAR, and this association was at the threshold of statistical significance for patients with daily sodium intake of less than 4 g (OR = 0.05, 95% CI 0.01 - 1.00). Conclusion: It was observed an association between adequate blood pressure control and HAR and uncontrolled with high potassium excretion and low sodium in patients with lower age and Caucasians. The result of the present study suggests a distinct relationship of sodium and potassium among patients with resistant and uncontrolled hypertension, observed in studies investigating this association with systemic arterial hypertension.

[1]  S. Yusuf,et al.  Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies , 2016, The Lancet.

[2]  L. Glynn,et al.  Educational interventions for improving control of blood pressure in patients with hypertension: a systematic review protocol , 2015, BMJ Open.

[3]  raquel joana de oliveira almeida,et al.  Epidemiologia da hipertensão arterial sistêmica e da insuficiência cardíaca no Brasil , 2014 .

[4]  S. Yusuf,et al.  Association of urinary sodium and potassium excretion with blood pressure. , 2014, The New England journal of medicine.

[5]  Rafael Moreira Claro,et al.  Estimativa de consumo de sódio pela população brasileira, 2008-2009 , 2013 .

[6]  A. P. Caldeira,et al.  Eficácia da educação em saúde no tratamento não medicamentoso da hipertensão arterial , 2013 .

[7]  W. Elliott,et al.  What is the prevalence of resistant hypertension in the United States? , 2012, Current opinion in cardiology.

[8]  Heather M. Tavel,et al.  Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients , 2012, Circulation.

[9]  G. F. Salles,et al.  I Posicionamento brasileiro sobre hipertensão arterial resistente , 2012 .

[10]  S. Yusuf,et al.  Urinary sodium and potassium excretion and risk of cardiovascular events. , 2011, JAMA.

[11]  N. Poulter,et al.  Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk , 2011, Journal of hypertension.

[12]  T. Giles,et al.  Resistant Hypertension: Concepts and Approach to Management , 2011, Current hypertension reports.

[13]  W. Elliott.  US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008 , 2011 .

[14]  B. Egan,et al.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. , 2010, JAMA.

[15]  M. Castanheira,et al.  Prevalence and Antimicrobial Susceptibility Profile of ESBL- and KPC-producing Enterobacteriaceae in the United States (2003 − 2008) , 2010 .

[16]  G. MacGregor,et al.  A comprehensive review on salt and health and current experience of worldwide salt reduction programmes , 2009, Journal of Human Hypertension.

[17]  W. Elliott.  Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research , 2009 .

[18]  S. Oparil,et al.  Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. , 2008, Archives of internal medicine.

[19]  Daniel W. Jones,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[20]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[21]  A. Naska,et al.  Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. , 2004, International journal of epidemiology.

[22]  H. Ueshima,et al.  A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen , 2002, Journal of Human Hypertension.

[23]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[24]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[25]  R. Piccini,et al.  How well is hypertension managed in the community? A population-based survey in a Brazilian city. , 1997, Cadernos de saude publica.

[26]  A. Logan,et al.  Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.

[27]  M. Weinberger,et al.  Salt sensitivity of blood pressure in humans. , 1996, Hypertension.

[28]  K. Srivastava,et al.  Potassium inhibits free radical formation. , 1994, Hypertension.

[29]  K. Itoh,et al.  A SIMPLE METHOD FOR ESTIMATING 24 H URINARY SODIUM AND POTASSIUM EXCRETION FROM SECOND MORNING VOIDING URINE SPECIMEN IN ADULTS , 1993, Clinical and experimental pharmacology & physiology.

[30]  M. Law,et al.  By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. , 1991, BMJ.

[31]  M. Law,et al.  By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. , 1991, BMJ.

[32]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[33]  K. Ando,et al.  Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. , 1984, Hypertension.

[34]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.